GRPR and prostate cancer: Lu-TacsBOMB5, Lu-LW01110, Lu-LW01142, and Lu-AMBA inhibited the binding of [125I-Tyr4]Bombesin to GRPR-expressing prostate cancer PC-3 cells in a dose-dependent manner (Figure 2A).